Veracyte, Inc. (VCYT) Stock Overview
Explore Veracyte, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Veracyte, Inc. (VCYT)
Key Financials
Key Financials
Market Cap
2B
P/E Ratio
15.82
EPS (TTM)
$2.00
ROE
0.09%
VCYT Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Veracyte, Inc. (NASDAQ: VCYT) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Veracyte, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of VCYT on the NASDAQ shows an RSI of 28.61, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $52.51 for the NASDAQ listing.
Key metrics behind Veracyte, Inc.'s NASDAQ-traded stock include a P/E ratio of 15.82 and a market capitalization of 2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of VCYT on the NASDAQ.